340B Orphan Drug Rule Review Passes 90-Day Mark

by Admin | May 2, 2013 3:50 pm

May 2, 2013—The Health Resources and Services Administration (HRSA) “is continuing to work” with the White House Office of Management and Budget (OMB) on a final regulation to implement the Affordable Care Act’s (ACA) restriction on 340B discounts for orphan drugs purchased by hospitals that became eligible for 340B under health care reform, a HRSA spokesperson said this morning.

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1]. Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Endnotes:

Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2013/05/340b-orphan-drug-rule-review-passes-90-day-mark/